key: cord-1013714-3vtf6oj0 authors: Iwamoto, Shusuke; Sato, Mitsuo P.; Hoshi, Yujiro; Otsuki, Naoki; Doi, Katsumi title: COVID-19 presenting as acute epiglottitis: a case report and literature review date: 2021-12-18 journal: Auris Nasus Larynx DOI: 10.1016/j.anl.2021.12.007 sha: f23b854b232894912511706d2fc6f364392f1c3f doc_id: 1013714 cord_uid: 3vtf6oj0 Coronavirus disease 2019 (COVID-19) occasionally causes acute laryngitis, requiring emergency treatment. Understanding the characteristic laryngeal findings can help diagnose COVID-19 earlier, prevent worsening infection, and properly manage airway obstruction. Herein, we report the case of a 44-year-old male with acute epiglottitis likely caused by COVID-19. On presentation, chest computed tomography (CT) showed no signs of pneumonia. However, the larynx had extensive necrotic-like erosive lesions resembling those of tuberculous laryngitis. COVID-19 was diagnosed by reverse-transcription polymerase chain reaction, and secondary bacterial superinfections were suspected after blood testing. The symptoms improved after administration of antibiotics (sulbactam sodium/ampicillin sodium), steroids (dexamethasone), and favipiravir. The patient developed a high fever on the sixth day of hospitalization, and pneumonia was identified on CT. Various culture tests, including tuberculosis, were negative. Thus, remdesivir was administered for COVID-19-induced pneumonia. The patient gradually recovered, was transferred to another hospital, and was discharged on the 35th day of hospitalization. Six previous case reports of COVID-19-induced acute epiglottitis suggested that acute epiglottitis preceded the onset of pneumonia. The laryngeal findings from this report may be useful for diagnosing COVID-19 that does not cause pneumonia and for bringing attention to pneumonia after a COVID-19 diagnosis. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a rapidly progressing respiratory disease that also affects the upper aerodigestive tract via angiotensin-converting enzyme 2 or transmembrane protease/serine subfamily member 2 receptors [1, 2] , causing a sore throat and odynophagia. There are reports of COVID-19-induced acute laryngitis requiring emergency treatment, indicated by acute epiglottitis in adults and croup in infancy [3] [4] [5] [6] [7] [8] [9] . Frequently, this requires urgent airway management, which generates aerosols and increases the risk of spreading the infection. Thus, understanding the laryngeal abnormalities associated with COVID-19 is essential. However, few laryngo-fiberscope images of COVID-19-induced acute laryngitis have been presented [5] . Additionally, the time between acute laryngitis onset and pneumonia has not been reviewed. Herein, we report a case of COVID-19-induced acute epiglottitis necessitating immediate hospitalization with subsequent pneumonia. Further, we reviewed previous reports on COVID-19-induced acute epiglottitis in adults to understand whether epiglottitis precedes the onset of pneumonia. A 44-year-old man complaining of sore throat and odynophagia was referred to our hospital after receiving an intravenous drip of ceftriaxone (2 g) for acute pharyngitis. The patient had no medical comorbidities and was a non-smoker. On presentation, the patient's vital signs were: body temperature, 37.1℃; heart rate, 122 beats per min; blood pressure, 138/88 mm Hg; and peripheral venous blood oxygen saturation (SpO 2 ) value, 99% in room air. There were no abnormalities in the pharynx or neck. The laryngeal fiberscope showed entirely necrotic-like erosions within the larynx, presenting as a red to white coarsely roughened surface that extended from the laryngeal side of the epiglottis to the subglottis and a red swollen mucosa with erosions in the bilateral arytenoid regions. Vocal cord paralysis was not observed ( Figure 1 ). Laboratory data revealed a white blood cell (WBC) count of 10 580/μL and a C-reactive protein (CRP) level of 14.075 mg/dL. Non-contrast chest computed tomography (CT) indicated no signs of pneumonia ( Figure 2A ). However, a nasopharyngeal swab tested positive for SARS-CoV-2 (N501Y type) by reverse-transcription polymerase chain reaction (RT-PCR), necessitating immediate hospitalization to manage the compromised airway. Figure 3 presents the treatment course. Sulbactam sodium/ampicillin sodium (SBT/ABPC) was administered for suspected secondary bacterial superinfections, and dexamethasone and favipiravir were administered for COVID-19. The laryngeal lesions and laboratory data improved, and the 6 SpO 2 did not decrease. However, fever resurged on the sixth day of hospitalization, and the WBC count and CRP level deteriorated. Culture tests, including tests for Mycobacterium, and rapid antigen tests for adenovirus, respiratory syncytial virus, and group A streptococci were performed on blood and sputum; all were negative. However, enhanced chest CT identified pneumonia ( Figure 2B ). COVID-19-induced pneumonia was diagnosed and treated with remdesivir [10] . The patient's pneumonia improved ( Figure 2C ), and he was transferred to another hospital and finally discharged on the 35th day of hospitalization. We report a case of acute epiglottitis caused by COVID-19, requiring immediate patient hospitalization owing to a compromised airway. Fiberoptic laryngoscopy revealed a diffusely erythematous larynx with necrotic-like erosions; this process included the subglottic mucosa and arytenoids. Table 1 provides information from a review of six cases of acute epiglottis caused by COVID-19. The descriptive laryngeal findings were similar to those of common acute epiglottitis. Only one report presented an image of acute epiglottis; the larynx was partially affected by erosive lesions [5] . These results suggest that necrotic-like erosive lesions may characterize COVID-19-induced acute laryngitis. Further, the lesions of acute laryngitis 7 are similar to those of tuberculous laryngitis [11] . Thus, diagnosis requires culture tests, as in our patient's case. Regarding the time course between acute epiglottitis and pneumonia in Table 1 , acute epiglottitis occurred before pneumonia in two of three cases. The onset of acute epiglottitis also preceded pneumonia in our case. Thus, these laryngeal findings may be associated with a COVID-19 diagnosis before the onset of pneumonia. Although RT-PCR is the gold standard for diagnosing COVID-19, it is time-consuming and occasionally provides false negative results. Therefore, a comprehensive diagnosis should be made based on the patient's general condition, symptoms, and other examinations. Chest CT is the most informative tool for diagnosing COVID-19, but is less informative for cases without or before the onset of pneumonia. In particular, there is limited time for examinations in patients with acute epiglottitis requiring emergency treatment, in whom the airway must be ensured before diagnostic test results are complete. As such, understanding the laryngeal findings of COVID-19-induced acute epiglottitis allows for earlier treatment and prevents worsening infection. More cases must be analyzed for confirmation of these findings, as only a few studies have been reported. As Table 1 shows, five of six patients required airway ensurance; four patients underwent tracheotomies, and one patient was intubated. In our patient's case, we would have attempted 8 to perform intubation first if severe dyspnea had developed, since the epiglottis was not swollen. Additionally, an operating room with negative pressure was prepared in the event that tracheostomy was necessary. As COVID-19-induced acute epiglottitis can result in pneumonia and the need to ensure the airway, physicians should make appropriate provisions for possible emergency management [12] . The extent of prophylactic airway management needed is difficult to determine; however, we suggest that the efficacy of steroids for a compromised airway should be confirmed first, in conjuction with hourly laryngeal examinations in the acute phase. Compared to case management for common acute epiglottitis, in which the epiglottis is swollen, we recommend performing tracheotomy earlier for COVID-19-induced acute epiglottitis. We perform PCR testing for COVID-19 on all patients to be hospitalized, in compliance with infection-preventive measures. Furthermore, full personal protective equipment (PPE), such as N-95 masks, gowns, caps, eye protection, and gloves, are used in ambulatory practice and treatment of inpatients who undergo procedures that carry the risk of aerosol generation. All medical team members are required to wear full PPE under conditions in which aerosols may be generated, such as using a laryngeal fiberscope. This patient had a mild fever; therefore, he was treated in a room adjusted with negative pressure in a different ward. 9 SARS-CoV-2 can lead to secondary bacterial infections. A meta-analysis of 3338 patients identified secondary bacterial infections in 6.9 % of COVID-19 patients [13] . We suspected that our patient had a secondary bacterial infection based on a neutrophil-dominated inflammatory reaction and susceptibility to SBT/ABPC. In the six reports of COVID-19-induced acute epiglottis, all patients received antibiotics and survived. Therefore, we recommend administering antibiotics and other medications, including steroids, for COVID-19-induced acute epiglottitis leading to airway obstruction. COVID-19-induced acute epiglottitis may precede pneumonia. Thus, understanding the laryngeal findings may prevent worsening infection. There are no conflicts of interest to declare. ** An image was published in the paper. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor Expression of ACE2 and TMPRSS2 proteins in the upper and lower aerodigestive tracts of rats: Implications on COVID 19 infections COVID-19 infection presenting with acute epiglottitis Acute epiglottitis due to COVID-19 infection Acute epiglottitis after COVID-19 infection Case report: Epiglottitis in the setting of COVID-19 Acute epiglottitis in a COVID-19 positive patient: A case report Epiglottitis case report: A unique presentation of COVID-19 infection Pediatric croup with COVID-19 Effect of remdesivir vs standard care on clinical status at 11 days in patients with 12 COVID-19: A randomized clinical trial Appearance and morphologic features of laryngeal tuberculosis using laryngoscopy: A retrospective cross-sectional study Laryngeal complications of COVID-19 Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis